[Methodological aspects of studying chemical preparations in a model of experimental influenzal infection].
Some methodologic approaches have been developed permitting most exhaustive characterization of antiviral and antitoxic activity of drugs in mice infected with toxigenic and nontoxigenic influenza A virus strains.
L E
LE
Nikitina
F S
FS
Noskov
E A
EA
Fridman
T V
TV
Peradze
D000276:Adjuvants, Immunologic; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004359:Drug Therapy, Combination; D009980:Influenza A virus / Q000187:drug effects; D007252:Influenza Vaccines / Q000627:therapeutic use; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000188:drug therapy* / Q000401:mortality; D012254:Ribavirin / Q000627:therapeutic use; D012299:Rimantadine / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D007252:Influenza Vaccines; D012299:Rimantadine; D012254:Ribavirin
Metodicheskie aspekty izucheniia khimiopreparatov na modeli éksperimental'noĭ grippoznoĭ infektsii.